Combination endocrine therapy following progression on first-line therapy

被引：0
|
作者：
O'Regan, R.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-ED04-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ED04-02
引用
收藏
页数：1
相关论文
共 50 条
  • [41] MAY DOXYCYCLINE-RIFAMPICIN COMBINATION BE THE FIRST-LINE THERAPY FOR OSTEOARTICULAR BRUCELLOSIS?
    Hocaoglu, S.
    Mesci, E.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S399 - S399
  • [42] Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension
    Kylhammar, David
    Persson, Liselotte
    Hesselstrand, Roger
    Radegran, Goran
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2014, 48 (04) : 223 - 233
  • [43] First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Mahipal, Amit
    Jin, Zhaohui
    BIOMEDICINES, 2022, 10 (06)
  • [44] Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer
    Yeon Hee Park
    Jae-Lyun Lee
    Baek-Yeol Ryoo
    Min-Hee Ryu
    Sung Hyun Yang
    Bong Seog Kim
    Dong Bok Shin
    Heung Moon Chang
    Tae Won Kim
    Young Jin Yuh
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 623 - 629
  • [45] Maintenance therapy or aEurotreatment holiday" after first-line therapy
    Serke, M.
    ONKOLOGE, 2011, 17 (08): : 709 - 714
  • [46] New effective Therapy Option in the First-line NSCLC Therapy
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (12)
  • [47] Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia
    Karlsson, C.
    Dahl, H.
    Lundin, J.
    Rossmann, E.
    Brytting, M.
    Mellstedt, H.
    Linde, A.
    Osterborg, A.
    BLOOD CANCER JOURNAL, 2011, 1 : e22 - e22
  • [48] Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia
    C Karlsson
    H Dahl
    J Lundin
    E Rossmann
    M Brytting
    H Mellstedt
    A Linde
    A Österborg
    Blood Cancer Journal, 2011, 1 : e22 - e22
  • [49] First-line and second-line antiretroviral therapy
    Calmy, A
    Pascual, F
    Ford, N
    LANCET, 2004, 364 (9431): : 329 - 329
  • [50] Rituximab as First-Line Maintenance Therapy Following Rituximab-Containing Therapy for Follicular LymphomaProfile Report
    Jamie D. Croxtall
    BioDrugs, 2011, 25 : 329 - 331
12345